Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatChemical/toxinWistar albinoBoth (3 males and 3 females per group)n = n = 6 per group; 36 rats total, plus n = 3 per dose in the…Oral70.7, 141.4 or 282.8 mg/kg (1/20, 1/10 and 1/5 of an LD50 o…Pretreatment for 7 days before carbon tetrachloride challenge
Model: Carbon tetrachloride in liquid paraffin (1:1), 1 mL/kg body weight intraperitoneally on day 7, 1 h after the final treatment dose
Doses of 70.7 and 141.4 mg/kg reduced transaminases, alkaline phosphatase and bilirubin and raised total protein; only 141.4 mg/kg improved antioxidant markers, and 282.8 mg/kg was ineffective, indicating a dose-specific effect.
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.